Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis

Christoph Kuemmerli, Christoph Tschuor, Meidai Kasai, Adnan A Alseidi, Gianpaolo Balzano, Stefan Bouwense, Marco Braga, Marielle Coolsen, Sara K Daniel, Christos Dervenis, Massimo Falconi, Dae Wook Hwang, Daniel J Kagedan, Song Cheol Kim, Harish Lavu, Tingbo Liang, Daniel Nussbaum, Stefano Partelli, Michael J Passeri, Nicolò PecorelliSastha Ahanatha Pillai, Venu G Pillarisetty, Michael J Pucci, Wei Su, Robert P Sutcliffe, Bobby Tingstedt, Marion van der Kolk, Dionisios Vrochides, Alice Wei, Caroline Williamsson, Charles J Yeo, Sabino Zani, Efstratios Zouros, Mohammed Abu Hilal*

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

BACKGROUND: This individual-patient data meta-analysis investigated the effects of enhanced recovery after surgery (ERAS) protocols compared with conventional care on postoperative outcomes in patients undergoing pancreatoduodenectomy.

METHODS: The Cochrane Library, MEDLINE, Embase, Scopus, and Web of Science were searched systematically for articles reporting outcomes of ERAS after pancreatoduodenectomy published up to August 2020. Comparative studies were included. Main outcomes were postoperative functional recovery elements, postoperative morbidity, duration of hospital stay, and readmission.

RESULTS: Individual-patient data were obtained from 17 of 31 eligible studies comprising 3108 patients. Time to liquid (mean difference (MD) -3.23 (95 per cent c.i. -4.62 to -1.85) days; P < 0.001) and solid (-3.84 (-5.09 to -2.60) days; P < 0.001) intake, time to passage of first stool (MD -1.38 (-1.82 to -0.94) days; P < 0.001) and time to removal of the nasogastric tube (3.03 (-4.87 to -1.18) days; P = 0.001) were reduced with ERAS. ERAS was associated with lower overall morbidity (risk difference (RD) -0.04, 95 per cent c.i. -0.08 to -0.01; P = 0.015), less delayed gastric emptying (RD -0.11, -0.22 to -0.01; P = 0.039) and a shorter duration of hospital stay (MD -2.33 (-2.98 to -1.69) days; P < 0.001) without a higher readmission rate.

CONCLUSION: ERAS improved postoperative outcome after pancreatoduodenectomy. Implementation should be encouraged.

Original languageEnglish
Pages (from-to)256-266
Number of pages11
JournalBritish Journal of Surgery
Volume109
Issue number3
DOIs
Publication statusPublished - 24 Feb 2022

Keywords

  • Enhanced Recovery After Surgery
  • Humans
  • Length of Stay
  • Pancreaticoduodenectomy/adverse effects
  • Patient Readmission
  • Postoperative Complications/prevention & control
  • Recovery of Function
  • COLORECTAL SURGERY
  • MANAGEMENT
  • IMPLEMENTATION
  • LENGTH-OF-STAY
  • FAST-TRACK SURGERY
  • PATHWAY
  • PANCREATIC SURGERY
  • COMPLICATIONS
  • PERIOPERATIVE CARE
  • PROGRAM

Cite this